|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.80 DKK | +0.51% |
|
-9.35% | -36.58% |
| Jun. 12 | After Euphoria, a Traffic Jam on the Multi-Billion Dollar Kilo-Highway |  |
| Jun. 11 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 508.64 | +71.96% | 14 | ||||||
| 846.68 | +8.05% | 15 | ||||||
| 145.96 | +46.39% | 16 | ||||||
| 106.48 | +36.71% | 19 | ||||||
| 197.62 | +101.96% | 21 | ||||||
| 40.49 | +50.93% | 22 | ||||||
| 2,313.13 | +42.87% | 15 | ||||||
| 49 | -7.77% | 16 | ||||||
| 547.64 | +31.9% | 17 | ||||||
| 810.5 | -14.59% | 6 | ||||||
| 678.71 | +41.17% | 14 | ||||||
| 21.28 | +103.44% | 13 | ||||||
| 148.86 | +87.12% | 20 | ||||||
| 88.17 | +18.31% | 12 | ||||||
| 128.12 | +3.96% | 16 | ||||||
| 104.7 | +49.25% | 20 | ||||||
| 99.09 | +53.91% | 14 | ||||||
| 13 | +83.1% | 3 | ||||||
| - | - | 770,000 | +72.45% | 1 | ||||
| 414.05 | -1.18% | 20 | ||||||
| Average | 38,863.11 | +44.00% | 15 | ||||||
| Weighted average by Cap. | 18,672.86 | +39.34% | 16 |
- Stock Market
- Stocks
- ZEAL Stock
- Sector Zealand Pharma A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
